For citations:
Nedosugova L.V., Petunina N.A., Galstyan K.O. Initial investigation of efficacy and safety of a new dipeptidyl peptidase-4 inhibitor, gosogliptin, for type 2 diabetes in Russia. Diabetes mellitus. 2014;17(4):81-86. https://doi.org/10.14341/DM2014481-86
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
